Auto Amazon Links: No products found. Blocked by captcha.
Scotland has pioneered a new health initiative by becoming the first region in the UK to implement newborn screening for Spinal Muscular Atrophy (SMA). This severe genetic disorder leads to progressive muscle weakening, and if untreated, it can drastically shorten life expectancy, often to as little as two years. Through a heel-prick test routinely done shortly after birth, babies with SMA can be identified early, enabling timely treatment that can significantly extend and improve their lives. Under a two-year pilot scheme, every newborn in Scotland will now undergo this screening.
The story of Grayce Pearson, a three-year-old from Milton, Glasgow, highlights the importance of early diagnosis. Grayce was found to have SMA type 2 as an infant, a condition where the absence of a critical muscle-building protein severely limits physical functions, including walking, swallowing, and even breathing. Grayce’s father, Tony, recalls, “Overnight she stopped kicking her legs and wasn’t attempting to crawl. She wasn’t trying to reach out for things.” This sudden loss of movement marked the onset of a challenging journey for their family.
Securing an early diagnosis is crucial since the effectiveness of treatments often depends on how quickly they are administered after nerve cells begin to deteriorate. Grayce’s mother, Carrie, shared how her concerns when Grayce was six months old were initially dismissed: “A child just doesn’t stop being able to physically move her legs altogether.” It took until Grayce was 14 months old for the diagnosis to be confirmed, by which point she was no longer eligible for gene therapy, a one-time treatment that might have enabled her to reach developmental milestones more fully. Now, Grayce uses medication that helps manage her symptoms, and her parents appreciate the progress she continues to make. Carrie noted, “Even the fact that she’s twisting around and reaching for stuff, she couldn’t do that at all.”
Despite the hardships, Grayce remains a joyful child who enjoys her nursery, music, and moving around in her wheelchair. Her father acknowledges the limits of current treatments but remains hopeful: “After two years on the medication they don’t tend to see progression after that but as a parent you remain optimistic to what you physically can do.” The introduction of newborn SMA screening in Scotland thus offers hope for future children with this condition, aiming to provide them with earlier access to life-enhancing therapies
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.